Metabolic Characteristics of Advanced Biliary Tract Cancer Using (18)F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications

BACKGROUND. In advanced biliary tract cancer (BTC), the metabolic landscape has not been evaluated by (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) yet. Furthermore, reports of the clinical implications of these metabolic features are limited. We aimed to evaluate the metabolic f...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Cho, Kyoung-Min, Oh, Do-Youn, Kim, Tae-Yong, Lee, Kyung Hun, Han, Sae-Won, Im, Seock-Ah, Kim, Tae-You, Bang, Yung-Jue
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2015
Matèries:
Hepatobiliary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4524751/
https://ncbi.nlm.nih.gov/pubmed/26099746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0356
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars